201 related articles for article (PubMed ID: 29086370)
1. MicroRNAs Change the Landscape of Cancer Resistance.
Zhu J; Zhu W; Wu W
Methods Mol Biol; 2018; 1699():83-89. PubMed ID: 29086370
[TBL] [Abstract][Full Text] [Related]
2. The emerging role of microRNAs in resistance to lung cancer treatments.
MacDonagh L; Gray SG; Finn SP; Cuffe S; O'Byrne KJ; Barr MP
Cancer Treat Rev; 2015 Feb; 41(2):160-9. PubMed ID: 25592062
[TBL] [Abstract][Full Text] [Related]
3. Impact of microRNAs in resistance to chemotherapy and novel targeted agents in non-small cell lung cancer.
Rolfo C; Fanale D; Hong DS; Tsimberidou AM; Piha-Paul SA; Pauwels P; Van Meerbeeck JP; Caruso S; Bazan V; Cicero G; Russo A; Giovannetti E
Curr Pharm Biotechnol; 2014; 15(5):475-85. PubMed ID: 24846062
[TBL] [Abstract][Full Text] [Related]
4. The role and mechanisms of action of microRNAs in cancer drug resistance.
Si W; Shen J; Zheng H; Fan W
Clin Epigenetics; 2019 Feb; 11(1):25. PubMed ID: 30744689
[TBL] [Abstract][Full Text] [Related]
5. The Roles of microRNAs in Regulating Chemotherapy Resistance of Non-Small Cell Lung Cancer.
Wei X; Shen X; Ren Y; Hu W
Curr Pharm Des; 2018 Feb; 23(39):5983-5988. PubMed ID: 29046142
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs as Regulators of Cisplatin Resistance in Lung Cancer.
Chen Y; Gao Y; Zhang K; Li C; Pan Y; Chen J; Wang R; Chen L
Cell Physiol Biochem; 2015; 37(5):1869-80. PubMed ID: 26584286
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs as therapeutic targets in chemoresistance.
Garofalo M; Croce CM
Drug Resist Updat; 2013; 16(3-5):47-59. PubMed ID: 23757365
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs in non-small cell lung cancer: Gene regulation, impact on cancer cellular processes, and therapeutic potential.
Petrek H; Yu AM
Pharmacol Res Perspect; 2019 Dec; 7(6):e00528. PubMed ID: 31859460
[TBL] [Abstract][Full Text] [Related]
9. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
Hu Y; Xu K; Yagüe E
Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
[TBL] [Abstract][Full Text] [Related]
10. Implications of MicroRNAs in the Treatment of Gefitinib-Resistant Non-Small Cell Lung Cancer.
Sin TK; Wang F; Meng F; Wong SC; Cho WC; Siu PM; Chan LW; Yung BY
Int J Mol Sci; 2016 Feb; 17(2):237. PubMed ID: 26891293
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients.
De Mattos-Arruda L; Bottai G; Nuciforo PG; Di Tommaso L; Giovannetti E; Peg V; Losurdo A; Pérez-Garcia J; Masci G; Corsi F; Cortés J; Seoane J; Calin GA; Santarpia L
Oncotarget; 2015 Nov; 6(35):37269-80. PubMed ID: 26452030
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
[TBL] [Abstract][Full Text] [Related]
13. microRNA regulation of cell viability and drug sensitivity in lung cancer.
Du L; Pertsemlidis A
Expert Opin Biol Ther; 2012 Sep; 12(9):1221-39. PubMed ID: 22731874
[TBL] [Abstract][Full Text] [Related]
14. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
[TBL] [Abstract][Full Text] [Related]
15. miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer.
Hu Y; Qiu Y; Yagüe E; Ji W; Liu J; Zhang J
Cell Death Dis; 2016 Jun; 7(6):e2291. PubMed ID: 27362808
[TBL] [Abstract][Full Text] [Related]
16. The role of microRNA in resistance to breast cancer therapy.
Robertson NM; Yigit MV
Wiley Interdiscip Rev RNA; 2014; 5(6):823-33. PubMed ID: 25044299
[TBL] [Abstract][Full Text] [Related]
17. Regulation Mechanism of MicroRNAs in Non-Small Cell Lung Cancer.
Gong FY; Bai T; Zhang DY; Huang CL; Lv J; Wang JL; Hu XD; Wang J; Liu W
Curr Pharm Des; 2018 Feb; 23(39):5973-5982. PubMed ID: 28714412
[TBL] [Abstract][Full Text] [Related]
18. MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2).
Jiao X; Zhao L; Ma M; Bai X; He M; Yan Y; Wang Y; Chen Q; Zhao X; Zhou M; Cui Z; Zheng Z; Wang E; Wei M
Breast Cancer Res Treat; 2013 Jun; 139(3):717-30. PubMed ID: 23780685
[TBL] [Abstract][Full Text] [Related]
19. An artificial lncRNA targeting multiple miRNAs overcomes sorafenib resistance in hepatocellular carcinoma cells.
Tang S; Tan G; Jiang X; Han P; Zhai B; Dong X; Qiao H; Jiang H; Sun X
Oncotarget; 2016 Nov; 7(45):73257-73269. PubMed ID: 27689326
[TBL] [Abstract][Full Text] [Related]
20. A systems biology approach to identify microRNAs contributing to cisplatin resistance in human ovarian cancer cells.
Liu W; Wang S; Zhou S; Yang F; Jiang W; Zhang Q; Wang L
Mol Biosyst; 2017 Oct; 13(11):2268-2276. PubMed ID: 28861582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
